Abstract
The effect of systemic administration of ritanserin (R 55667), a 5-hydroxytryptamine (5-HT2) receptor antagonist, on midbrain dopamine (DA) neurons was studied with single cell recording techniques in the chloral hydrate anesthetized male rat. Dopamine cells of the zona compacta, substantia nigra (ZC-SN) and the ventral tegmental area (VTA) were identified by established criteria. Ritanserin (0.5–2.0 mg/kg, IV) dose-dependently increased both the burst firing and firing rate of the midbrain DA neurons. These effects were prevented by endogenous 5-HT depletion through pretreatment with the 5-HT synthesis inhibitor para-chlorophenylalanine (PCPA, 300 mg/kg, IP, x3), which did not significantly alter the firing characteristics of the midbrain DA cells when given alone. These results suggest that 5-HT exerts an inhibitory control of midbrain DA cell activity mediated by 5-HT2 receptors. The stimulatory effect of ritanserin on midbrain DA systems might contribute to some of its clinical effects, such as improvement of mood, drive and motivation as well as its therapeutic actions in parkinsonism and type II schizophrenia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aghajanian GK (1981) The modulatory role of serotonin at multiple receptors in brain. In: Jacobs BL, Gelperin A (eds) Serotonin neurotransmission and behavior. MIT Press, Cambridge Massachusetts, pp 156–185
Aghajanian GK, Bunney BS (1974) Dopaminergic and non-dopaminergic neurons of the substantia nigra: differential responses to putative transmitters. In: Boissier JR, Hippius H, Pichot P (eds) Proceedings: 9th International Congress of the C.I.N.P. Excerpta Medica, Amsterdam, pp 444–452
Bersani G, Grispini A, Marini S, Pasini A, Valducci M, Ciani N (1986) Neuroleptic-induced extrapyramidal side effects: clinical perspectives with ritanserin (R 55667), a new selective 5-HT2 receptor blocking agent. Curr Ther Res 40:492–499
Björklund A, Lindvall O (1984) Dopamine-containing systems in the CNS. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroamatomy, vol 2: classical transmitters in the CNS, Part 1. Elsevier, Amsterdam New York Oxford, pp 55–112
Bozarth MA (1986) Neural basis of psychomotor stimulant and opiate reward: evidence suggesting the involvement of a common dopaminergic system. Behav Brain Res 22:107–116
Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560–571
Collingridge GL, Davies J (1981) The influence of stimulation and putative neurotransmitters on identified neurones in the rat substantia nigra. Brain Res 212:345–359
Colpaert FC, Meert TF, Niemegeers CJE, Janssen PAJ (1985) Behavioral and 5-HT antagonist effect of ritanserin: a pure and selective antagonist of LSD discrimination in rat. Psychopharmacology 86:45–54
Crow TJ, Cross AJ, Cooper SJ, Deakin JFW, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R, Corsellis JAN, Chambers DR, Blessed G, Perry EK, Perry RH, Tomlinson BE (1984) Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 23:1561–1569
Davies MF, Deisz RA, Prince DA, Peroutka SJ (1987) Two distinct effects of 5-hydroxytryptamine on single cortical neurons. Brain Res 423:347–352
Dray A, Gonye TJ, Oakley NR, Tanner T (1976) Evidence for the existence of a raphe projection to the substantia nigra in rat. Brain Res 113:45–57
Fibiger HC, Miller JJ (1977) An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphe nucleus to the substantia nigra in the rat. Neuroscience 2:975–987
Fuxe K (1965) Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta Physiol Scand 64 Suppl 247:37–85
Gelders Y, Vanden Bussche G, Reyntjens A, Janssen P (1986) Serotonin-S2 receptor blockers in the treatment of chronic schizophrenia. Clin Neuropharmacol 9 Suppl 4:325–327
Gerstein GL (1960) Analysis of firing patterns in single neurons. Science 131:1811–1812
Glennon RA, Young R, Rosecrans JA (1983) Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Eur J Pharmacol 91:189–196
Grace AA, Bunney BS (1983) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons — 1. Identification and characterization. Neuroscience 10:301–315
Grace AA, Bunney BS (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877–2890
Grenhoff J, Aston-Jones G, Svensson TH (1986) Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128:351–358
Guyenet PG, Aghajanian GK (1978) Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra. Brain Res 150:69–84
Hervé D, Pickel VM, Joh TH, Beaudet A (1987) Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435:71–83
Imai H, Steindler DA, Kitai ST (1986) The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J Comp Neurol 243:363–380
Kammen DP van, Mann LS, Sternberg DE, Scheinin M, Ninan PT, Marder SR, van Kammen WB, Rieder RO, Linnoila M (1983) Dopamine-β-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy. Science 220:974–977
Karoum F, Karson CN, Bigelow LB, Lawson WB, Wyatt RJ (1987) Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia. Arch Gen Psychiatry 44:604–607
Koe BK, Weissman A (1966) p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther 154:499–516
Leysen JE (1984) Problems in in vitro receptor binding studies and identification and role of serotonin receptor sites. Neuropharmacology 23:247–254
Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PFM, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin, a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27:600–611
Maertens de Noordhout A, Delwaide PJ (1986) Open pilot trial of ritanserin in Parkinsonism. Clin Neuropharmacol 9:480–484
Meco G, Marini S, Lestingi L, Modarelli F, Agnoli A (1986) Efficacy of ritanserin on tremor and abnormal involuntary movements in Parkinsons's disease. Abstract, 15th C.I.N.P. Congress, San Juan, Puerto Rico, p 298
Mita T, Hanada S, Nishino N, Kuno T, Nakai H, Yamadori T, Mizoi Y, Tanaka C (1986) Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 21:1407–1414
Nedergaard S, Bolam JP, Greenfiled SA (1988a) Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature 333:174–177
Nedergaard S, Hopkins C, Greenfield SA (1988b) Do nigro-striatal neurones possess a discrete dendritic modulatory mechanism? Electrophysiological evidence from the actions of amphetamine in brain slices. Exp Brain Res 69:444–448
Papp M, Bal A (1986) Motivational versus motor impairment after haloperidol injection or 6-OHDA lesions in the ventral tegmental area or substantia nigra in rats. Physiol Behav 38:773–779
Parent A, Descarries L, Beaudet A (1981) Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of (3H)5-hydroxytryptamine. Neuroscience 6:115–138
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, Sydney
Pazos A, Cortés R, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain II. Serotonin-2 receptors. Brain Res 346:231–249
Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21:123–139
Rasmussen K, Aghajanian GK (1986) Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists. Brain Res 385:395–400
Reubi J-C, Emson PC (1978) Release and distribution of endogenous 5-HT in rat substantia nigra. Brain Res 139:164–168
Reynolds GP, Arnold L, Rossor MN, Iversen LL, Mountjoy CQ, Roth M (1984) Reduced binding of (3H) ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type. Neurosci Lett 44:47–51
Reyntjens A, Gelders YG, Hoppenbrouwers M-LJA, Vanden Bussche G (1986) Thymostenic effects of ritanserin (R 55667), a centrally acting serotonin-S2 blocker. Drug Dev Res 8:205–211
Stanley M, Mann JJ (1983) Increased serotonin-2 binding sites in the frontal cortex of suicide victims. Lancet I:214–216
Steinbusch HWM (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat — cell bodies and terminals. Neuroscience 6:557–618
Ugedo L, Grenhoff J, Svensson TH (1987) Stimulation of midbrain dopamine neuronal activity by ritanserin, a novel 5-HT2 antagonist. Soc Neurosci Abstr 13:481
Viscardi E, Bernardini G, German DC (1987) Amphetamine-induced inhibition of ventral tegmental area dopaminergic neuronal impulse flow: in vitro studies in the mouse. Soc Neurosci Abstr 13:491
Wang RY (1981) Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization. Brain Res Rev 3:123–140
Werner G, Mountcastle VB (1963) The variability of central neural activity in a sensory system, and its implications for the central reflection of sensory events. J Neurophysiol 26:958–977
Williams J, Davies JA (1983) The involvement of 5-hydroxytryptamine in the release of dendritic dopamine from slices of rat substantia nigra. J Pharm Pharmacol 35:734–737
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ugedo, L., Grenhoff, J. & Svensson, T.H. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 98, 45–50 (1989). https://doi.org/10.1007/BF00442004
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442004